Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
about
Imatinib in chronic myeloid leukemia: an overviewTyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trialsChronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trials.Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.Epidemiology of chronic myeloid leukaemia: an update.Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting.Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib.Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing country.
P2860
Q26865086-81A8521E-92CF-406E-9100-45EA802C8A8CQ30242015-87922272-6990-498E-9F75-5507D783E4C4Q35873909-FE56881D-389A-4F25-B586-FF01CA9F2AA4Q35949910-0935147A-0098-421E-A1BC-6EB567756F69Q36804884-6681D89D-738D-4ACE-B223-9F31DB98BA9FQ37026032-DA121E11-AB83-496D-B16E-1C21145A191AQ37098856-CE4AF543-CA5A-4C13-908A-FE5A2929BB40Q37329232-3DC502C5-7722-40E6-84E4-72A6A857C506Q37418970-D3AE3065-5A9D-4C90-B3B5-B1D406D44E77Q38199143-3556F192-261D-4E34-B464-0FDBAC71149CQ38392709-167A3198-AC58-438F-9819-0BC6FE0F9493Q39591396-C0AF58C1-6CFA-4A8B-8AFB-0447D85222EFQ39637488-4BCD28DA-2A35-4E71-ADD7-B2EA3BFB348BQ40821920-3A46C3BF-E87E-4AAB-A4CF-C61AA8E6FE2FQ41164222-67782CDC-8715-48BD-A8D8-EFFC996E61EBQ44394170-F430D386-FAF4-4E83-8FA0-83A9DF4EDCF0Q48108936-9D08BC1D-8229-4791-A6A6-2798C86122E4Q54333450-95FC65EF-C750-4E8D-93D7-4728F61903D5
P2860
Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@en
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@nl
type
label
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@en
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@nl
prefLabel
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@en
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@nl
P2093
P2860
P1476
Treatment of consecutive patie ...... lation-based CAMELIA Registry.
@en
P2093
Edgar Faber
Elena Tóthová
Eva Demečková
Imrich Markuljak
Jaroslava Voglová
Juraj Chudej
Karel Indrák
Ludmila Demitrovičová
Marie Jarošová
P2860
P304
P356
10.1111/J.1600-0609.2011.01637.X
P577
2011-08-01T00:00:00Z